Thursday’s Midday Stock Update: SeaDrill LTD (SDRL), Halcon Resources (HK), OncoSec Medical (ONCS), Dynavax (DVAX), Ambarella (AMBA)

By Carrie Williams

So far Thursday, May 17, NASDAQ is up 0.25% and the S&P is up 0.33%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; SeaDrill LTD (NYSE:SDRL), Halcon Resources (NYSE:HK), OncoSec Medical (NASDAQ:ONCS), Dynavax (NASDAQ:DVAX) and Ambarella (NASDAQ:AMBA).

SeaDrill LTD is up 11.57% in midday trading to $0.60. Shares opened today at $0.54. The company has a 52-week low of $0.15 and a 52-week high of $0.00.

Halcon Resources is up 10.92% in midday trading to $5.54. Shares opened today at $4.99. The company has a 52-week low of $3.69 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $10.00, marking a 100.40% potential upside from current levels. In a report issued on April 24, Stephens Inc analyst Will Green reiterated a Buy rating on HK, with a price target of $10, which represents a potential upside of 100% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Halcon Resources has been positive based on 66 corporate insider transactions. This sentiment is slightly higher than the average sector sentiment of insiders.

OncoSec Medical is down -10.63% in midday trading to $1.59. Shares opened today at $1.78. The company has a 52-week low of $0.88 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.50, marking a 152.81% potential upside from current levels. In a report issued on May 9, H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on ONCS, with a price target of $4, which implies an upside of 125% from current levels.

See today’s analyst top recommended stocks >>

Dynavax is down -8.54% in midday trading to $16.60. Shares opened today at $18.15. The company has a 52-week low of $5.35 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $29.80, marking a 64.19% potential upside from current levels. In a report released yesterday, Cantor Fitzgerald analyst Elemer Piros reiterated a Buy rating on DVAX, with a price target of $27, which represents a potential upside of 49% from where the stock is currently trading. Over the last 3 months, the insider sentiment on Dynavax has been negative based on 19 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Ambarella is down -7.91% in midday trading to $50.30. Shares opened today at $54.62. The company has a 52-week low of $40.06 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $67.00, marking a 22.67% potential upside from current levels. In a report issued on March 29, Needham analyst Quinn Bolton maintained a Hold rating on AMBA. Separately, on March 28, Oppenheimer’s Andrew Uerkwitz assigned a Buy rating to the stock and has a price target of $70.

Trending Stocks Based on Insider Activity >>